SS
ROIV icon

SBI Securities’s Roivant Sciences ROIV Stock Holding History

SBI Securities’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8K Sell
418
-200
-32% -$5.91K ﹤0.01% 1663
2026
Q1 		$17.1K Sell
618
-615
-50% -$15.8K ﹤0.01% 1524
2025
Q4 		$26.8K Buy
1,233
+1,166
+1,740% +$23K ﹤0.01% 1329
2025
Q3 		$1.01K Sell
67
-10
-13% -$124 ﹤0.01% 2687
2025
Q2 		$868 Sell
77
-1,200
-94% -$13K ﹤0.01% 2744
2025
Q1 		$12.9K Sell
1,277
-8
-0.6% -$87 ﹤0.01% 1501
2024
Q4 		$15.2K Buy
+1,285
New +$15.2K ﹤0.01% 1467

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

SBI Securities's ROIV Position: Q2 2026 in Review

SBI Securities reduced its Roivant Sciences (ROIV) stake by 32% in Q2 2026, selling an estimated $5.91K and leaving 418 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1663.

SBI Securities first reported a position in ROIV in Q4 2024 and has held it in 7 quarters since. The position peaked at $26.8K in Q4 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • SBI Securities held 418 shares of Roivant Sciences worth $14.8K as of Q2 2026.
  • SBI Securities sold 200 Roivant Sciences shares in Q2 2026, an estimated $5.91K.
  • Roivant Sciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1663 holding.
  • SBI Securities first reported a position in Roivant Sciences in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Roivant Sciences position peaked at $26.8K in Q4 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.